Torrent Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
3,785.65
-16 (-0.42%)
BSENSE

Dec 05

BSE+NSE Vol: 93.14 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Lupin
Sun Pharma.Inds.
Divi's Lab.
Torrent Pharma
Dr Reddy's Labs
Aurobindo Pharma
Alkem Lab
Cipla
Zydus Lifesci.
Abbott India
Mankind Pharma
Why is Torrent Pharmaceuticals Ltd. ?
1
High Management Efficiency with a high ROCE of 24.08%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.01 times
3
Poor long term growth as Net Sales has grown by an annual rate of 8.93% over the last 5 years
4
The company has declared Positive results for the last 9 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 22.56 times
  • ROCE(HY) Highest at 27.85%
  • PAT(Q) Highest at Rs 600.71 cr.
5
With ROCE of 30.4, it has a Very Expensive valuation with a 12.5 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 12.94%, its profits have risen by 24.6% ; the PEG ratio of the company is 2.4
6
High Institutional Holdings at 25.2%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Consistent Returns over the last 3 years
  • Along with generating 12.94% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Torrent Pharma should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Torrent Pharma for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Torrent Pharma
12.61%
0.58
22.16%
Sensex
4.89%
0.40
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.93%
EBIT Growth (5y)
13.04%
EBIT to Interest (avg)
8.68
Debt to EBITDA (avg)
1.40
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.92
Tax Ratio
25.82%
Dividend Payout Ratio
56.67%
Pledged Shares
0
Institutional Holding
25.20%
ROCE (avg)
23.21%
ROE (avg)
22.06%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
59
Industry P/E
34
Price to Book Value
15.23
EV to EBIT
41.01
EV to EBITDA
32.74
EV to Capital Employed
12.48
EV to Sales
10.67
PEG Ratio
2.42
Dividend Yield
0.68%
ROCE (Latest)
30.43%
ROE (Latest)
25.66%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 22.56 times

ROCE(HY)

Highest at 27.85%

PAT(Q)

Highest at Rs 600.71 cr.

DEBT-EQUITY RATIO(HY)

Lowest at 0.33 times

NET SALES(Q)

Highest at Rs 3,302.00 cr

PBDIT(Q)

Highest at Rs 1,083.00 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 32.80%

PBT LESS OI(Q)

Highest at Rs 831.00 cr.

EPS(Q)

Highest at Rs 17.46

-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 5.51 times

Loading Valuation Snapshot...
Here's what is working for Torrent Pharma
Operating Profit to Interest - Quarterly
Highest at 22.56 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit After Tax (PAT) - Quarterly
Highest at Rs 600.71 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 3,302.00 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,083.00 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 32.80%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 831.00 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 17.46
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly
Lowest at 0.33 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Torrent Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 5.51 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio